Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2024
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Journal: Molecular cancer
Published: December 15, 2023
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 27, 2023
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment.
Journal: Journal for immunotherapy of cancer
Published: January 25, 2022
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown.
Journal: Cancer discovery
Published: November 03, 2020
Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptome.
Journal: Scientific reports
Published: February 01, 2019
High-throughput Phenotyping of Lung Cancer Somatic Mutations.
Journal: Cancer cell
Published: December 13, 2017
CD19-positive antibody-secreting cells provide immune memory.
Journal: Blood advances
Published: December 11, 2017
Last Updated: 09/26/2026